A severe, generalized myopathy developed in 2 children treated with labetalol. An 11-year-old girl and a 14-year-old boy demonstrated proximal weakness and markedly elevated creatine kinase levels during labetalol therapy. Clinical improvement began immediately when labetalol administration was halted; muscle strength was normal within 2 months. Muscle biopsies were consistent with rhabdomyolysis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0887-8994(90)90122-h | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!